These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2786520

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
    Clarke AM, Zemcov SJ.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101.
    Barry AL, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN, Pfaller MA.
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):794-8. PubMed ID: 3145868
    [Abstract] [Full Text] [Related]

  • 25. Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
    Dornbusch K, Kronvall G, Göransson E, Mörtsell E.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():43-52. PubMed ID: 2732143
    [Abstract] [Full Text] [Related]

  • 26. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E, Kolek B, Bonner DP, Valera L, Minassian B, Fung-Tomc J.
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [Abstract] [Full Text] [Related]

  • 27. In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
    Dornbusch K, Henning C, Lindén E.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():109-17. PubMed ID: 2732133
    [Abstract] [Full Text] [Related]

  • 28. In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
    Van der Auwera P, Ernst F, Grenier P, Glupczynski Y, Husson M, Klastersky J.
    J Antimicrob Chemother; 1987 Aug; 20(2):179-89. PubMed ID: 3478328
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC, Chin NX, Labthavikul P.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The in-vitro activity of O-demethylfortimicin.
    Neu HC.
    J Antimicrob Chemother; 1983 Feb; 11(2):181-5. PubMed ID: 6833173
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
    [Abstract] [Full Text] [Related]

  • 37. FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration.
    Della Bruna C, Jabes D, Rossi R, Younes G, Castellani P.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():119-28. PubMed ID: 2659570
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R, Ravagnan G.
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.